Jupiter Research Capital (Asia) Ltd’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.44M Buy
+8,916
New +$1.49M 0.16% 149

Other funds holding AZN

Jupiter Research Capital (Asia) Ltd's AZN Position: Q3 2026 in Review

Jupiter Research Capital (Asia) Ltd opened a new position in AstraZeneca (AZN) in Q3 2026: 8,916 shares worth $1.44M. The stake represents 0.16% of the portfolio and ranks #149 among its holdings.

1,377 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Jupiter Research Capital (Asia) Ltd held 8,916 shares of AstraZeneca worth $1.44M as of Q3 2026.
  • AstraZeneca was a new Jupiter Research Capital (Asia) Ltd position in Q3 2026.
  • AstraZeneca made up 0.16% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #149 holding.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.